Junkkari, A. http://orcid.org/0000-0001-8715-1749
Sintonen, H. http://orcid.org/0000-0003-1252-0946
Danner, N. http://orcid.org/0000-0002-7094-4432
Jyrkkänen, H. K.
Rauramaa, T. http://orcid.org/0000-0002-2250-327X
Luikku, A. J. http://orcid.org/0000-0003-2864-1953
Koivisto, A. M.
Roine, R. P.
Viinamäki, H.
Soininen, H. http://orcid.org/0000-0002-2785-9937
Jääskeläinen, J. E.
Leinonen, V. http://orcid.org/0000-0002-4282-4687
Funding for this research was provided by:
Kuopion Yliopistollinen Sairaala
Sigrid Juséliuksen Säätiö
State Research Funding
Suomen Lääketieteen Säätiö
University of Eastern Finland (UEF) including Kuopio University Hospital
Article History
Received: 29 December 2020
Revised: 14 February 2021
Accepted: 15 February 2021
First Online: 2 March 2021
Compliance with ethical standards
:
: Dr. Sintonen has developed the 15D. Other authors report no disclosures.
: Data is available from the corresponding author upon reasonable request.
: This study was approved by the Research Ethics Board of KUH. The study was conducted in accordance with the World Medical Association's Helsinki Declaration. Informed written consent was obtained from all patients. In cases of severe cognitive decline, the consent was obtained from the patient’s primary caregiver or family member.